Chances are you have family or friends who have struggled with weight loss for years, losing weight on the latest ... "We don't yet know all the long-term side effects as this is a new trend among non ...

Two in three adults in England are overweight or obese - and 26 per cent of us have learned all we know about treatments like ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

"For healthcare providers, these findings suggest that anti-obesity medications may offer dual benefits," one doctor reports today.

Results from the SURMOUNT-1 trial show that weekly injections of tirzepatide could stop the progression from pre-diabetes to ...

After a nurse died after just two weight-loss injections of Mounjaro - which is approved for use on the NHS - here's ...

But between shortages, high out of pocket costs and the need for weekly injections, the medication is not suited for everyone ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

Amgen addresses safety concerns for its weight loss drug MariTide after new data suggests a potential 4% reduction in bone ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...